Clinical efficacy analysis of radioactive (125)I particle implantation for the treatment of pelvic local recurrence of cervical cancer after radiotherapy.
The Effect of Computed Tomography-Guided (125)I Radioactive Particle Implantation in Treating Cancer and Its Pain.
Lu W, Du P, Yang C, Jiang F, Xie P, Yang J, Zhang Z, Ma J.
Cancer Biother Radiopharm. 2018 Jun;33(5):176-181. doi: 10.1089/cbr.2017.2425.
PMID:29916744
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
Salem R, Gordon AC, Mouli S, Hickey R, Kallini J, Gabr A, Mulcahy MF, Baker T, Abecassis M, Miller FH, Yaghmai V, Sato K, Desai K, Thornburg B, Benson AB, Rademaker A, Ganger D, Kulik L, Lewandowski RJ.
Gastroenterology. 2016 Dec;151(6):1155-1163.e2. doi: 10.1053/j.gastro.2016.08.029. Epub 2016 Aug 27.
PMID:27575820
Treating cancerous large airway stenosis with staging radioactive particle implantation guided by computed tomography and fiber bronchoscopy: a clinical study.
Mao Y, Yang X, Li M, Guo W, Zhang W.
World J Surg Oncol. 2017 Aug 3;15(1):149. doi: 10.1186/s12957-017-1216-2.
PMID:28774331
Clinical efficacy of iodine-125 radioactive particle implantation with deep hyperthermia in malignant tumor treatment: A retrospective analysis.
Yuan Y, Kou Y, Yu J, Zhang S, Chen S, Wang R, Wang Z, Zhou J, Li C.
The Combined Antitumor Effects of (125)I Radioactive Particle Implantation and Cytokine-Induced Killer Cell Therapy on Xenograft Hepatocellular Carcinoma in a Mouse Model.
Zhang J, Wu N, Lian Z, Feng H, Jiang Q, Chen X, Gong J, Qiao Z.
Technol Cancer Res Treat. 2017 Dec;16(6):1083-1091. doi: 10.1177/1533034617732204. Epub 2017 Sep 25.
PMID:29332456
Application of preoperative three-dimensional model design in radioactive particle implantation for advanced pancreatic cancer.
Liu Y, Lyu SC, Wang XQ, Wang YB.
Onco Targets Ther. 2018 Dec 4;11:8685-8693. doi: 10.2147/OTT.S164880. eCollection 2018.
PMID:30584326
Recent progress in radioactive seed implantation brachytherapy of non-small cell lung cancer: a narrative review.
Wang X, Tian S, Shi H, Qin H, Zhang W, Dong Y, Bai C.
J Thorac Dis. 2024 Mar 29;16(3):2167-2176. doi: 10.21037/jtd-23-1600. Epub 2024 Mar 25.
PMID:38617768
Evaluation of risk factors for difficult-to-control pain (VAS score > 3) at two months after late-stage non-small cell lung cancer treatment with iodine-125 radioactive particle implantation combined with chemotherapy.